New Antidiabetics Need Head-To-Head Trials With Existing Regimens – AHRQ
Executive Summary
New insulin therapies need to be compared to traditional insulin therapies in studies with regimens that resemble usual clinical practice, the Agency for Healthcare Research and Quality says